MRNA vs OXY · rev $145.0M vs rev $21.59B
Moderna Inc (MRNA) versus OXY (OXY) — a side-by-side from cached financials, not a winner call.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stephane Bancel.
OXY (OXY) common stock.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
Latest reported OXY revenue for 2025-12-31 was $21.59B. Net income was $2.37B. Revenue was down 19.2% from 2024-12-31 to 2025-12-31. OXY currently screens at market cap $0.
MRNA currently screens at market cap $24.52B. OXY currently screens at market cap $0.
Not investment advice. Open the MRNA and OXY stock pages for the full models.
Not investment advice.